You are here
ECCO2017 – European Cancer Congress
From evidence to practice in multidisciplinary cancer care
This congress, which is intended for a multidisciplinary audience, will put new evidence, mainly phase III data, into perspective by critically reviewing it in expert panels, including a discussion of the clinical benefits and costs of novel treatments. Topics of this scientific meeting will include the use of evidence-based information for deciding on treatment as well as health economics and outcome research. This year’s programme will particularly focus on immunotherapy, personalised medicine, the evolving healthcare systems and the future of cancer treatment, with particular regard to access to innovation, disparities in cancer care and the diminishing oncology workforce. The programme will also include regulatory sessions on newly approved drugs and innovation in local regional treatment. Besides, ECCO2017 will shed light on ECCO policy initiatives, centred around the oncology workforce and quality cancer care, making sure cancer is at the top of the EU public health agenda.
ECCO is an open forum for its members. The first day of ECCO2017 will feature societies’ meetings for their members and the oncology community: the European Oncology Nursing Society (EONS), the European Organisation for Research and Treatment of Cancer (EORTC), the European School of Oncology (ESO), the European Society of Surgical Oncology (ESSO), the European SocieTy for Therapeutic Radiology and Oncology (ESTRO), and the European Society for Paediatric Oncology (SIOPE).